Hui Li
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 0.2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- MicroRNA in disease regulation 16
- Cancer-related molecular mechanisms research 8
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 18
- Lung Cancer Diagnosis and Treatment 9
- Co-authors
- Hourong Cai (16 shared papers)Timothy S. Blackwell (5 shared papers)Canmao Xie (7 shared papers)Dan Sun (1 shared paper)Xiao Han (1 shared paper)Jie Ren (1 shared paper)Xiaoxia Lü (1 shared paper)Zhisheng Liu (1 shared paper)
- Journals
- PLoS ONE (6 papers)Scientific Reports (5 papers)Oncotarget (5 papers)Emerging Microbes & Infections (4 papers)Frontiers in Microbiology (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hui Li
294 papers receiving 14.6k citations
Hui Li's Hit Papers
Peers
Comparison fields: 5 of 178
- Virology 1.4k
- Infectious Diseases 4.6k
- Molecular Medicine 815
- General Dentistry 35
- Cancer Research 990
Countries citing papers authored by Hui Li
This map shows the geographic impact of Hui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Li more than expected).
Fields of papers citing papers by Hui Li
This network shows the impact of papers produced by Hui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Li. The network helps show where Hui Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 301 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 Hit paper breakdown → | 2020 | 4065 |
| 2 | Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection Hit paper breakdown → | 2008 | 1558 |
| 3 | Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study Hit paper breakdown → | 2020 | 959 |
| 4 | 2017 | 486 | |
| 5 | 2020 | 456 | |
| 6 | 1996 | 300 | |
| 7 | 2019 | 216 | |
| 8 | 2012 | 210 | |
| 9 | 2018 | 159 | |
| 10 | 2013 | 138 | |
| 11 | 2014 | 137 | |
| 12 | 2020 | 137 | |
| 13 | 2019 | 128 | |
| 14 | 2020 | 117 | |
| 15 | 2012 | 103 | |
| 16 | 2020 | 101 | |
| 17 | Mechanisms of columnar metaplasia and squamous regeneration in experimental Barrett's esophagus. | 1994 | 95 |
| 18 | 2018 | 89 | |
| 19 | 2016 | 81 | |
| 20 | 2015 | 80 |
About Hui Li
Hui Li is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Immunology, Oncology and Epidemiology, having authored 301 papers that have together received 15k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers), MicroRNA in disease regulation (16 papers), COVID-19 Clinical Research Studies (12 papers), Immune Response and Inflammation (9 papers), Lung Cancer Diagnosis and Treatment (9 papers), Cancer-related molecular mechanisms research (8 papers), Antibiotic Resistance in Bacteria (8 papers) and Influenza Virus Research Studies (6 papers). The work is most often cited by research in Virology (1.4k citations), Infectious Diseases (4.6k citations), Molecular Medicine (815 citations), General Dentistry (35 citations) and Cancer Research (990 citations). Hui Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hourong Cai, Timothy S. Blackwell, Canmao Xie, Dan Sun, Xiao Han, Jie Ren, Xiaoxia Lü, Zhisheng Liu, Yifeng Luo and Timothy Rutland Walsh. Their work appears in journals such as PLoS ONE, Scientific Reports, Oncotarget, Emerging Microbes & Infections and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.